相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
Laura Keller et al.
BRITISH JOURNAL OF CANCER (2021)
A Real-World Study in Advanced Non-Small Cell Lung Cancer with KRAS Mutations
Lei Lei et al.
TRANSLATIONAL ONCOLOGY (2020)
Diagnostic Accuracy of Droplet Digital PCR and Amplification Refractory Mutation System PCR for Detecting EGFR Mutation in Cell-Free DNA of Lung Cancer: A Meta-Analysis
Caichen Li et al.
FRONTIERS IN ONCOLOGY (2020)
Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages
Nicolas Guibert et al.
EUROPEAN RESPIRATORY REVIEW (2020)
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer
Elisabetta Zulato et al.
BRITISH JOURNAL OF CANCER (2020)
Is tissue still the issue in detecting molecular alterations in lung cancer?
Chong-Kin Liam et al.
RESPIROLOGY (2020)
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
David S. Hong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Comparison of droplet digital PCR and direct Sanger sequencing for the detection of the BRAFV600E mutation in papillary thyroid carcinoma
Zhuo Wang et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2019)
New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness
Haitang Yang et al.
FRONTIERS IN ONCOLOGY (2019)
Optimisation of robust singleplex and multiplex droplet digital PCR assays for high confidence mutation detection in circulating tumour DNA
Vicky Rowlands et al.
SCIENTIFIC REPORTS (2019)
Assessing the Concordance of Genomic Alterations between Circulating-Free DNA and Tumour Tissue in Cancer Patients
Leila Jahangiri et al.
CANCERS (2019)
The emerging treatment landscape of targeted therapy in non-small-cell lung cancer
Min Yuan et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications
Federica Zito Marino et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)
False-Positive Plasma Genotyping Due to Clonal Hematopoiesis
Yuebi Hu et al.
CLINICAL CANCER RESEARCH (2018)
Droplet Digital PCR for Mutation Detection in Formalin-Fixed, Paraffin-Embedded Melanoma Tissues A Comparison with Sanger Sequencing and Pyrosequencing
Ashleigh C. McEvoy et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2018)
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
Christian Rolfo et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target
Marta Roman et al.
MOLECULAR CANCER (2018)
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis et al.
CANCER DISCOVERY (2018)
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
D. Planchard et al.
ANNALS OF ONCOLOGY (2018)
Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reaction
F. Janku et al.
ANNALS OF ONCOLOGY (2017)
Integrating liquid biopsies into the management of cancer
Giulia Siravegna et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS-mutated lung adenocarcinoma
Nicolas Guibert et al.
LUNG CANCER (2016)
Prognostic and Predictive Value in KRAS in Non-Small-Cell Lung Cancer A Review
Kevin Wood et al.
JAMA ONCOLOGY (2016)
KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients
Monica Garzon et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?
Jiri Polivka et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)
KRAS-G12C Mutation is Associated with Poor Outcome in Surgically Resected Lung Adenocarcinoma Response
Ernest Nadal et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer
Jian-Ming Xu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer
Anneli Dowler Nygaard et al.
LUNG CANCER (2013)
The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients
Carlos Camps et al.
LUNG CANCER (2011)
Potential Clinical Significance of a Plasma-Based KRAS Mutation Analysis in Patients with Advanced Non-Small Cell Lung Cancer
Shuhang Wang et al.
CLINICAL CANCER RESEARCH (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Origin and prognostic value of circulating KRAS mutations in lung cancer patients
O. Gautschi et al.
CANCER LETTERS (2007)
Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer?
C Camps et al.
LUNG CANCER (2005)
分享论文
